Newsletter Subject

Woah Sarepta...

From

mtatradeoftheday.com

Email Address

TradeoftheDay@mb.mtatradeoftheday.com

Sent On

Fri, Jun 21, 2024 11:58 AM

Email Preheader Text

Pharma company skyrockets in premarket trading after latest FDA approval. Green believes a $1,000 in

Pharma company skyrockets in premarket trading after latest FDA approval. [Trade of the Day Wake-Up Watchlist] Good Morning Wake-Up Watchlisters! While you’re sipping coffee you’ll see stock futures were down on Friday after a pullback from megcap tech and chip stocks. Nvidia dropped 1.5% in premarket trading, and other chipmakers Broadcom, Super Micro Computer and Qualcomm were also down. Despite the drop, all major Wall Street indexes are on track to close the week higher. Tech stocks and AI companies have been a major contributor to record market highs in 2024. But the fun could just be getting started. There are still plenty of AI companies that could stand to gain in the near future, which is why Oxford Club Chief Investment Strategist Alexander Green just released his [“Magnificent Seven Tech Stocks.”]( Green believes a $1,000 investment in these 7 stocks could make you a millionaire in less than six years. [Click here to discover Alexander Green’s magnificent 7 stocks.]( Here’s a look at the top-moving stocks this morning. Sarepta Therapeutics (Nasdaq: SRPT) Sarepta Therapeutics is up 38.98% in premarket trading after the Food and Drug Administration approved its Duchenne muscular dystrophy gene therapy for all patients age 4 and older. Sarepta is the current leader in Duchenne muscular dystrophy treatment. Investors often use bullish indicators like FDA approval as a reason to buy a stock, but the truth is there’s a specific way to time trades that result in consistent gains. In [The War Room]( we use what we call the “Perfect Timing Pattern” to make gains in both bull and bear markets. [Click here to learn more about The Perfect Timing Pattern.]( Gilead Sciences Inc. (Nasdaq: GILD) Gilead Sciences is up 5.10% in premarket trading after receiving positive feedback from its latest HIV drug. Its twice-annual shot proved 100% effective in preventing HIV infections in cisgender women. [**URGENT AI BIOTECH EVENT**]( In the coming days, an AI biotech - currently trading for less than $10 - is expected to make a bombshell announcement. And I do mean BOMBSHELL. These announcements have historically been known to generate FAR more explosive gains than FDA approval... and in a MUCH shorter time... As much as 509% MORE gains in some cases. Companies that have made similar announcements have seen their shares positively SOAR. [Ambrx Biopharma]( [And on June 27 at 2 p.m. ET]( America's #1 stock catalyst expert wants to give you all the details. Including why this coming announcement could be bigger and more important than anything we've seen in a lifetime. [Claim a free spot to attend right here.]( Teledyne Technologies Incorporated (NYSE: TDY) Teledyne is up 5.50% in premarket trading after the company revealed its latest unmanned ground vehicle, the SUGV 325. The robot represents a growth opportunity as higher demand for unmanned vehicles in rescue missions for civillians could drive demand. Other companies including Northrop Grumman and BAE Systems also could see improved demand as they both hold strong presence in the unmanned vechicle space. Those are the biggest stock movers for today. Happy trading! The Wake-Up Watchlist Research Team [Trading Legend Reveals New AI-Powered Tool]( [Nate Bear]( Nate Bear, the trader who turned $37k into $2.7 Million in 4 years, just revealed his groundbreaking wealth-building initiative... A cutting-edge trading research tool powered-by AI that is finding explosive setups at an UNGODLY speed. See the details for yourself: [ Watch The DEMO Here]( [Monument Traders Alliance] Monument Traders Alliance You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, [click here](. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 [Website]( | [Privacy Policy]( Keep the emails you value from falling into your spam folder. [Whitelist Trade of the Day](. © 2024 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.

Marketing emails from mtatradeoftheday.com

View More
Sent On

08/12/2024

Sent On

06/12/2024

Sent On

05/12/2024

Sent On

05/12/2024

Sent On

04/12/2024

Sent On

04/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.